Yusuf Khwaja Hamied
Chairman at CIPLA LIMITED
Net worth: 2 528 M $ as of 2024-04-29
Profile
Yusuf Khwaja Hamied is Non-Executive Chairman for Cipla Ltd. and Chairman at Cipla Medpro Pty Ltd. (a subsidiary of Cipla Ltd.). He received a doctorate from the University of Cambridge.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CIPLA LTD
18.64% | 2023-06-29 | 150,521,183 ( 18.64% ) | 2 528 M $ | 2024-04-29 |
Yusuf Khwaja Hamied active positions
Companies | Position | Start |
---|---|---|
CIPLA LIMITED | Chairman | 1972-07-20 |
Cipla Medpro Pty Ltd.
Cipla Medpro Pty Ltd. BiotechnologyHealth Technology Cipla Medpro Pty Ltd. engages in pharmaceutical products production. Its offers asthma, allergy, colds and flu, complementary medicines, cough, diabetes management, Reydin, anthelmintic, antibiotics, antidiabetics and neuropsychiatry products. The company was founded in 1995 and is headquartered in Bellville, South Africa. | Chairman | - |
Training of Yusuf Khwaja Hamied
University of Cambridge | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CIPLA LIMITED | Health Technology |
Private companies | 1 |
---|---|
Cipla Medpro Pty Ltd.
Cipla Medpro Pty Ltd. BiotechnologyHealth Technology Cipla Medpro Pty Ltd. engages in pharmaceutical products production. Its offers asthma, allergy, colds and flu, complementary medicines, cough, diabetes management, Reydin, anthelmintic, antibiotics, antidiabetics and neuropsychiatry products. The company was founded in 1995 and is headquartered in Bellville, South Africa. | Health Technology |
- Stock Market
- Insiders
- Yusuf Khwaja Hamied